Clinical observations and reliability of the phytomedecine KOMODETM in hepatitis (B and C) therapy in Alango Foundation African Medecine Hospitals in Cameroon

TRACK 4 : Global Health / One Health
CBS21_ORA_1225
Clinical observations and reliability of the phytomedecine KOMODETM in hepatitis (B and C) therapy in Alango Foundation African Medecine Hospitals in Cameroon
Bibiane Aimée Wandji;
Pepin NKENG-EFOUET-ALANGO*;
Pierre Watcho;

  1. 13
  2. 1
* Email : pnfalango@yahoo.fr

1Research unit of Animal Physiology and Phytopharmacology, PO. BOX 67 University of Dschang.
2Department of Chemistry, Faculty of Science, PO. BOX 67 University of Dschang.
3Private Higher Institute of training in African Phytotherapy and Pharmacopoeia of Yaoundé.
*Correspondance: pnfalango@yahoo.fr

Viral hepatitis are infections associated with a high mortality rate especially in developing countries. Generally high cost of hepatitis therapy makes synthetic self-medication the main therapeutic responses. Besides, there is African medicine that people do not know about. The main objective of this research was to demonstrate the reliability of the clinical observations made as well as the clinical evaluation of phytomedicines used for the treatment of viral hepatitis. During the internship at the Reference Hospital of African Medicine of the Alango Fondation, appropriate diagnostic methods were used (consultation of the patient, hypothesis of diagnosis, verification of the hypotheses by the prescription of the biomedical analyses and the interpretation of the results in order to establish a good diagnosis), 268 patients suffering from viral hepatitis B or C who came for consultation in this clinic were subjected to phytomedicines. The different symptoms of hepatitis B or C were also followed at this period. Among the 268 patients, 220 had hepatitis B and 48 had hepatitis C, a respective percentage of 82.1% and 17.9%. We obtained 149 participants healed from hepatitis B and 42 from hepatitis C, with a respective percentage of 67.42 and 89.4%. It is observed here that the cure is more evident in patients aged from 0 to 19 (adolescents) and 60 to 99 years than in those aged 20 to 59 years. The present study shows that the management method of viral hepatitis patients in the Alango Foundation is reliable, thus validating the proven effectiveness of the African medicine, here, with regard to viral hepatitis B or C. Phase 2 of the clinical evaluation of KOMODETM in African medicine has been completed. This phase is a key step in the standardization of drugs.
Key words: Viral hepatitis, Clinical observation, African medicine, Phytotherapy, Alango Foundation.